MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 106 filers reported holding MEI PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $67,000 | -39.1% | 173,760 | -4.5% | 0.00% | – |
| Q2 2022 | $110,000 | -21.4% | 181,980 | -21.8% | 0.00% | – |
| Q1 2022 | $140,000 | -81.1% | 232,726 | -16.3% | 0.00% | – |
| Q4 2021 | $742,000 | -25.1% | 277,987 | -22.5% | 0.00% | – |
| Q3 2021 | $991,000 | -8.2% | 358,789 | -5.2% | 0.00% | – |
| Q2 2021 | $1,079,000 | +188.5% | 378,463 | +247.5% | 0.00% | – |
| Q1 2021 | $374,000 | +57.1% | 108,896 | +20.7% | 0.00% | – |
| Q4 2020 | $238,000 | -82.2% | 90,201 | -79.0% | 0.00% | -100.0% |
| Q3 2020 | $1,339,000 | -19.2% | 428,967 | +6.9% | 0.00% | 0.0% |
| Q2 2020 | $1,658,000 | +255.0% | 401,408 | +38.3% | 0.00% | – |
| Q1 2020 | $467,000 | -41.6% | 290,296 | -9.9% | 0.00% | – |
| Q4 2019 | $799,000 | +32.7% | 322,197 | -10.1% | 0.00% | – |
| Q3 2019 | $602,000 | -40.3% | 358,509 | -11.2% | 0.00% | – |
| Q2 2019 | $1,009,000 | -14.0% | 403,767 | +5.7% | 0.00% | – |
| Q1 2019 | $1,173,000 | +14.4% | 381,966 | -1.6% | 0.00% | – |
| Q4 2018 | $1,025,000 | -46.6% | 388,266 | -12.9% | 0.00% | -100.0% |
| Q3 2018 | $1,921,000 | +9.4% | 445,698 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,756,000 | +98.2% | 445,698 | +4.1% | 0.00% | – |
| Q1 2018 | $886,000 | -0.2% | 428,136 | +1.3% | 0.00% | – |
| Q4 2017 | $888,000 | +120.9% | 422,779 | +181.9% | 0.00% | – |
| Q3 2017 | $402,000 | – | 149,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|